Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹38.40 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹38.40 Cr |
| Fresh Issue | ₹36.47 Cr |
| Face Value | ₹5 Per Equity Share |
| Issue Price | ₹60.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | AATMAJ |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Nirbhay Capital Services Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Incorporated in 2014, Aatmaj Healthcare Limited runs multi-specialty hospitals, under the name Jupiter Hospitals, offering medical care at affordable rates.
The company provides inpatient and outpatient healthcare services through its hospitals in Vadodara, Gujarat with an aggregate bed capacity of 130 beds extendable up to 175 beds. As on December 31, 2022, they have conducted an aggregate healthcare treatment, including surgeries, of over 17,000 patients, consisting of more than 4,000 patients and more than 13,000 OPD patients including Covid-19 Patients.
The company's primary check-up services include hemoglobin check, lipid profile, general tests, renal profile, blood sugar, MCV, ESR, MCH, MCHC, liver profile, and lipid profile.
Aatmaj Healthcare specializes in Nephrology and Uro surgery/Vascular surgery, Orthopedics, Joint replacement, Polytrauma care, Obstetric, Gynaecology, ENT, Ophthalmology, Plastic Surgery, and Neuro Surgery.
The company is a part of Ayushman Bharat-Pradhan Mantri Jan ArogyaYojana, a flagship scheme of the Government of India which was launched and recommended by the National Health Policy 2017, to achieve the vision of universal health coverage (UHC).
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/Prepayment in full or part of existing secured debt of the Company | 9.00 |
| 2 | Funding the Working Capital Requirements of the Company | 6.00 |
| 3 | Purchase of medical equipments for hospitals of our Company and/or newly acquired or set up hospitals | 9.13 |
| 4 | Our inorganic growth initiatives through acquisitions and other strategic initiatives | 6.20 |
| 5 | General Corporate Expenses | 4.97 |
| Period Ended | 31 Dec 2022 | 30 Sep 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|---|
| Assets | 30.32 | 23.23 | 17.19 | 9.80 | 9.33 |
| Total Income | 20.48 | 13.45 | 21.81 | 17.26 | 4.37 |
| Profit After Tax | 5.77 | 2.91 | 4.92 | 4.12 | -0.27 |
| NET Worth | 13.88 | 11.02 | 8.11 | 3.19 | -0.93 |
| Reserves and Surplus | 5.78 | 5.62 | 6.76 | 1.84 | -2.28 |
| Total Borrowing | 12.18 | 8.94 | 5.18 | 4.33 | 8.76 |
| Amount in ₹ Crore | |||||
| KPI | Mar 31, 2022 |
|---|---|
| ROE | 61% |
| ROCE | 69.84% |
| Debt / Equity | 0.14% |
| RoNW | 60.68% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 5.41 | |
| P/E (x) | 17.6 | |
| Promoter Holding | 88.89% | 63.72% |
| Market Cap | ₹135.60 Cr. | |
